000			02188 a2200613 4500
005			20250516134903.0
264		0	_c20130619
008			201306s 0 0 eng d
022			_a1096-8652
024	7		_a10.1002/ajh.23423 _2doi
040			_aNLM _beng _cNLM
100	1		_aAvivi, Irit
245	0	0	_aStrikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era. _h[electronic resource]
260			_bAmerican journal of hematology _cMay 2013
300			_a400-5 p. _bdigital
500			_aPublication Type: Comparative Study; Evaluation Study; Journal Article
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntibodies, Monoclonal, Murine-Derived _xadministration & dosage
650	0	4	_aAntineoplastic Agents _xadministration & dosage
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage
650	0	4	_aCohort Studies
650	0	4	_aCombined Modality Therapy
650	0	4	_aCyclophosphamide _xadministration & dosage
650	0	4	_aDoxorubicin _xadministration & dosage
650	0	4	_aFalse Negative Reactions
650	0	4	_aFemale
650	0	4	_aFluorodeoxyglucose F18
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aLymphoma, Large B-Cell, Diffuse _xdiagnosis
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMultimodal Imaging
650	0	4	_aPositron-Emission Tomography
650	0	4	_aPredictive Value of Tests
650	0	4	_aPrednisone _xadministration & dosage
650	0	4	_aRadiopharmaceuticals
650	0	4	_aRecurrence
650	0	4	_aRemission Induction
650	0	4	_aRetrospective Studies
650	0	4	_aRituximab
650	0	4	_aTomography, X-Ray Computed
650	0	4	_aVincristine _xadministration & dosage
700	1		_aZilberlicht, Ariel
700	1		_aDann, Eldad J
700	1		_aLeiba, Ronit
700	1		_aFaibish, Tal
700	1		_aRowe, Jacob M
700	1		_aBar-Shalom, Rachel
773	0		_tAmerican journal of hematology _gvol. 88 _gno. 5 _gp. 400-5
856	4	0	_uhttps://doi.org/10.1002/ajh.23423 _zAvailable from publisher's website
999			_c22518091 _d22518091